June 2021
Destiny Pharma consultant Professor Dale Gerding updates on recurrent C. difficile infec...
April 2021
Proactive Results Interview
April 2021
Developing Novel Medicines that Prevent Serious Infections
March 2021
Proactive Elevator Pitch
February 2021
Destiny Pharma presents an overview of the Company at the Shares Spotlight Investor Even...
January 2021
Neil Clark talks to Proactive London’s Katie Pilbeam about the XF-73 Phase 2b clinical...
January 2021
Destiny Pharma presents at the Proactive One2One live investment forum
January 2021
Proactive ONE2ONE Investor Forum – Thursday January 21st from 6:00 pm GMT